These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6827912)

  • 21. Quantification of Tricyclic Antidepressants in Serum Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
    Crutchfield CA; Breaud AR; Clarke WA
    Methods Mol Biol; 2016; 1383():265-70. PubMed ID: 26660194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
    Wen B; Ma L; Zhu M
    Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver.
    Otton SV; Brinn RU; Gram LF
    Drug Metab Dispos; 1988; 16(1):15-7. PubMed ID: 2894945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of tricyclic antidepressants with cholestyramine in vitro.
    Bailey DN; Coffee JJ; Anderson B; Manoguerra AS
    Ther Drug Monit; 1992 Aug; 14(4):339-42. PubMed ID: 1519310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency.
    Dayer P; Kronbach T; Eichelbaum M; Meyer UA
    Biochem Pharmacol; 1987 Dec; 36(23):4145-52. PubMed ID: 3689440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous absorption of tricyclic antidepressants: amitriptyline, nortriptyline, imipramine, and desipramine.
    Bailey DN
    J Anal Toxicol; 1990; 14(4):217-8. PubMed ID: 2395341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The excessive activity of cytochrome P450 system in ALS--the metabolic ratio of sparteine].
    Kaneko K; Atsumi T; Miyataka T
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1251-5. PubMed ID: 2605831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine.
    Skjelbo E; Brøsen K; Hallas J; Gram LF
    Clin Pharmacol Ther; 1991 Jan; 49(1):18-23. PubMed ID: 1988236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease].
    Yoshino H; Hattori Y; Imai H; Narabayashi H; Chiba K
    Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tricyclic antidepressants (imipramine, desipramine, amitriptyline, nortriptyline)].
    Yasuda K
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():934-7. PubMed ID: 8753592
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinidine kinetics after a single oral dose in relation to the sparteine oxidation polymorphism in man.
    Brøsen K; Davidsen F; Gram LF
    Br J Clin Pharmacol; 1990 Feb; 29(2):248-53. PubMed ID: 2306418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
    Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
    Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
    Caldara M; Marmiroli N
    Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain.
    Barańczyk-Kuźma A; Kuźma M; Gutowicz M; Kaźmierczak B; Sawicki J
    Acta Biochim Pol; 2004; 51(1):207-12. PubMed ID: 15094841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver metabolic reactions: tertiary amine N-dealkylation, tertiary amine N-oxidation, N-oxide reduction, and N-oxide N-dealkylation. I. Tricyclic tertiary amine drugs.
    Bickel MH
    Arch Biochem Biophys; 1972 Jan; 148(1):54-62. PubMed ID: 4400523
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of propranolol by rat liver microsomes and its inhibition by phenothiazine and tricyclic antidepressant drugs.
    Shand DG; Oates JA
    Biochem Pharmacol; 1971 Jul; 20(7):1720-3. PubMed ID: 5163100
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative pharmacogenetics of sparteine and debrisoquine.
    Inaba T; Vinks A; Otton SV; Kalow W
    Clin Pharmacol Ther; 1983 Mar; 33(3):394-9. PubMed ID: 6825393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.